# LRIF1

## Overview
The LRIF1 gene encodes the protein ligand-dependent nuclear receptor interacting factor 1, which plays a pivotal role in chromatin organization and gene expression regulation. This protein is primarily involved in the epigenetic regulation of chromatin structure, particularly through its interaction with the SMCHD1 protein, which is crucial for repressing the D4Z4 repeat and preventing the expression of the DUX4 gene, a process vital for normal muscle function and the prevention of facioscapulohumeral muscular dystrophy (FSHD) (Hamanaka2020Homozygous; Šikrová2023SMCHD1). LRIF1 also facilitates the interaction of SMCHD1 with heterochromatin protein 1 (HP1γ) at specific chromatin sites, contributing to X-chromosome inactivation and the regulation of HOX genes, which are essential for axial patterning and skeletal development (Xue2022HOX; Burlet2021Identification). As a nuclear protein, LRIF1 is integral to various cellular processes, including differentiation and development, by modulating gene activity (Šikrová2023SMCHD1).

## Function
The LRIF1 gene encodes a protein that plays a crucial role in chromatin organization and gene expression regulation in healthy human cells. LRIF1 is involved in the epigenetic regulation of the D4Z4 repeat array, which is essential for maintaining chromatin structure in somatic cells. It interacts with the SMCHD1 protein to repress the D4Z4 repeat, thereby preventing the inappropriate expression of the DUX4 gene, which is toxic in myogenic cells (Hamanaka2020Homozygous; Šikrová2023SMCHD1). This repression is vital for normal muscle function and the prevention of facioscapulohumeral muscular dystrophy (FSHD) (Hamanaka2020Homozygous).

LRIF1 also mediates the interaction of SMCHD1 with heterochromatin protein 1 (HP1γ) at trimethylated histone H3 lysine 9 (H3K9me3)-modified chromatin sites, which is crucial for X-chromosome inactivation (Burlet2021Identification). In addition, LRIF1 is implicated in the regulation of HOX genes, contributing to axial patterning and skeletal development (Xue2022HOX). The protein is active in the nucleus, where it influences cellular processes such as differentiation and development by modulating the activity of specific genes (Šikrová2023SMCHD1).

## Clinical Significance
Mutations in the LRIF1 gene have been implicated in several diseases, notably facioscapulohumeral muscular dystrophy type 2 (FSHD2) and neurodevelopmental disorders (NDDs). In FSHD2, mutations in LRIF1 lead to the relaxation of D4Z4 chromatin and inappropriate expression of the DUX4 gene, contributing to muscle weakness and dystrophy. This condition is characterized by a homozygous mutation in LRIF1, resulting in the absence of the long isoform of the LRIF1 protein, which is crucial for maintaining the repressed state of the D4Z4 repeat (Hamanaka2020Homozygous; Šikrová2023SMCHD1).

LRIF1 is also associated with neurodevelopmental disorders. Mutations affecting LRIF1 can disrupt chromosome segregation during mitosis, leading to insufficient neuronal stem cell proliferation and central nervous system underdevelopment. This can result in conditions such as microcephaly and neuronal migration disorders (BenMahmoud2022A).

In the context of cancer, a novel somatic mutation in LRIF1 has been identified in a case of atypical B-cell chronic lymphocytic leukemia (B-CLL). This mutation may lead to haploinsufficiency of LRIF1 in the nucleus, potentially contributing to the pathogenesis of B-CLL (Burlet2021Identification). These findings underscore the clinical significance of LRIF1 mutations and their potential impact on various diseases.

## Interactions
LRIF1, or ligand-dependent nuclear receptor interacting factor 1, is known to interact with several proteins involved in chromatin regulation and gene expression. It directly interacts with SMCHD1, a chromatin-modifying enzyme, through its coiled-coil domain, which is crucial for recruiting SMCHD1 to chromatin, particularly at the inactive X chromosome in mammals (Xue2022HOX). This interaction is essential for the regulation of Hox gene expression and the maintenance of chromatin structure.

In the context of facioscapulohumeral muscular dystrophy type 2 (FSHD2), LRIF1 is involved in the repression of the D4Z4 repeat, working alongside SMCHD1 to prevent inappropriate expression of the DUX4 gene. LRIF1's recruitment to the D4Z4 repeat is partially dependent on SMCHD1, although SMCHD1 recruitment is independent of LRIF1 (Šikrová2023SMCHD1). LRIF1 also interacts with HP1γ at trimethylated histone H3 lysine 9 (H3K9me3)-modified chromatin sites, which is important for X-chromosome inactivation (Burlet2021Identification).

LRIF1 has been implicated in the shutdown of nuclear hormone receptor signaling, specifically retinoic acid, and may have roles at centromeric repeats and telomeres (Burlet2021Identification). These interactions highlight LRIF1's role in chromatin remodeling and transcriptional regulation.


## References


[1. (BenMahmoud2022A) Afif Ben-Mahmoud, Kyung Ran Jun, Vijay Gupta, Pinang Shastri, Alberto de la Fuente, Yongsoo Park, Kyung Chul Shin, Chong Ae Kim, Aparecido Divino da Cruz, Irene Plaza Pinto, Lysa Bernardes Minasi, Alex Silva da Cruz, Laurence Faivre, Patrick Callier, Caroline Racine, Lawrence C. Layman, Il-Keun Kong, Cheol-Hee Kim, Woo-Yang Kim, and Hyung-Goo Kim. A rigorous in silico genomic interrogation at 1p13.3 reveals 16 autosomal dominant candidate genes in syndromic neurodevelopmental disorders. Frontiers in Molecular Neuroscience, October 2022. URL: http://dx.doi.org/10.3389/fnmol.2022.979061, doi:10.3389/fnmol.2022.979061. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2022.979061)

[2. (Burlet2021Identification) Bénédicte Burlet, Selim Ramla, Cyril Fournier, Maria Jimena Abrey-Recalde, Camille Sauter, Marie-Lorraine Chrétien, Cédric Rossi, Yannis Duffourd, Sylviane Ragot, Céline Buriller, Benjamin Tournier, Caroline Chapusot, Nathalie Nadal, Jessica Racine, Julien Guy, François Bailly, Laurent Martin, Olivier Casasnovas, Jean-Noël Bastie, Denis Caillot, Juliette Albuisson, Cyril Broccardo, Catherine Thieblemont, Laurent Delva, Marc Maynadié, Romain Aucagne, and Mary B. Callanan. Identification of novel, clonally stable, somatic mutations targeting transcription factors pax5 and nkx2-3, the epigenetic regulator lrif1, and braf in a case of atypical b-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21). Molecular Case Studies, 7(1):a005934, February 2021. URL: http://dx.doi.org/10.1101/mcs.a005934, doi:10.1101/mcs.a005934. This article has 2 citations.](https://doi.org/10.1101/mcs.a005934)

[3. (Hamanaka2020Homozygous) Kohei Hamanaka, Darina Šikrová, Satomi Mitsuhashi, Hiroki Masuda, Yukari Sekiguchi, Atsuhiko Sugiyama, Kazumoto Shibuya, Richard J.L.F. Lemmers, Remko Goossens, Megumu Ogawa, Koji Nagao, Chikashi Obuse, Satoru Noguchi, Yukiko K. Hayashi, Satoshi Kuwabara, Judit Balog, Ichizo Nishino, and Silvère M. van der Maarel. Homozygous nonsense variant in lrif1 associated with facioscapulohumeral muscular dystrophy. Neurology, June 2020. URL: http://dx.doi.org/10.1212/WNL.0000000000009617, doi:10.1212/wnl.0000000000009617. This article has 118 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/WNL.0000000000009617)

[4. (Šikrová2023SMCHD1) Darina Šikrová, Alessandra M. Testa, Iris Willemsen, Anita van den Heuvel, Stephen J. Tapscott, Lucia Daxinger, Judit Balog, and Silvère M. van der Maarel. Smchd1 and lrif1 converge at the fshd-associated d4z4 repeat and lrif1 promoter yet display different modes of action. Communications Biology, June 2023. URL: http://dx.doi.org/10.1038/s42003-023-05053-0, doi:10.1038/s42003-023-05053-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-023-05053-0)

[5. (Xue2022HOX) Shifeng Xue, Thanh Thao Nguyen Ly, Raunak S. Vijayakar, Jingyi Chen, Joel Ng, Ajay S. Mathuru, Frederique Magdinier, and Bruno Reversade. Hox epimutations driven by maternal smchd1/lrif1 haploinsufficiency trigger homeotic transformations in genetically wildtype offspring. Nature Communications, June 2022. URL: http://dx.doi.org/10.1038/s41467-022-31185-8, doi:10.1038/s41467-022-31185-8. This article has 6 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-31185-8)